dc.contributor.author | Dominguez-Molina, Beatriz | |
dc.contributor.author | Tarancon-Diez, Laura | |
dc.contributor.author | Milanés-Guisado, Yusnelkis | |
dc.contributor.author | Genebat, Miguel | |
dc.contributor.author | Rodriguez, Carmen | |
dc.contributor.author | Resino, Salvador | |
dc.contributor.author | Gonzalez-García, Juan | |
dc.contributor.author | Rallón, Norma | |
dc.contributor.author | León, Agathe | |
dc.contributor.author | García, Felipe | |
dc.contributor.author | Del Romero, Jorge | |
dc.contributor.author | Viciana, Pompeyo | |
dc.contributor.author | Lopez-Cortes, Luis F | |
dc.contributor.author | Leal, Manuel | |
dc.contributor.author | Ruiz-Mateos, Ezequiel | |
dc.contributor.author | Casado, Concepcion | |
dc.contributor.author | Pernas, Maria | |
dc.contributor.author | Lopez-Galindez, Luis Cecilio | |
dc.contributor.author | Benito, José Miguel | |
dc.date.accessioned | 2020-09-29T09:08:49Z | |
dc.date.available | 2020-09-29T09:08:49Z | |
dc.date.issued | 2020-09 | |
dc.identifier.citation | J Int AIDS Soc. 2020 Sep;23(9):e25607. | es_ES |
dc.identifier.uri | http://hdl.handle.net/20.500.12105/11081 | |
dc.description.abstract | HIV-controllers have the ability to spontaneously maintain viraemia at low or undetectable levels in the absence of antiretroviral treatment. Furthermore, HIV-controllers seem to have a superior capacity to spontaneously clear hepatitis C virus (HCV) compared to non HIV-controllers. Some of these subjects eventually lose HIV-controller status (transient controllers), whereas some HIV-controllers show a persistent natural HIV control (persistent controllers). We aimed to analyse whether persistent controllers have superior capacity to spontaneously clear HCV compared to transient controllers.
We recruited HIV-controllers from January 1981 up to October 2016 with available antibodies to HCV (anti-HCV) data (n = 744). Factors associated with HIV spontaneous control in relation to HCV status were analysed in persistent and transient HIV-controllers with anti-HCV positive (n = 202 and n = 138 respectively) in comparison with 1700 HCV positive non HIV-controllers recruited from January 1981 up to March 2018, bivariate and multivariate analyses, following a logistic regression model, were applied. In addition, the factors related to the loss and time to lose HIV-controller status were explored (n = 744) using Log rank test and Kaplan-Meier curves, in this case the multivariate analysis consisted in a Cox regression model.
A higher frequency of HCV spontaneous clearance was found in persistent HIV-controllers (25.5%) compared to non-controllers (10.2%). After adjusting for potential confounders, as sex, age, HIV transmission risk, CD4+ T-cell nadir and time of follow-up, HCV clearance was independently associated with persistent HIV spontaneous control (p = 0.002; OR (95% CI) = 2.573 (1.428 to 4.633)), but not with transient spontaneous control (p = 0.119; 1.589 (0.888 to 2.845)). Furthermore, persistent HIV-controllers were more likely to spontaneously clear the HCV in comparison with transient controllers (p = 0.027; 0.377 (0.159 to 0.893). Finally, not to lose or lengthen the time of losing this control was independently associated with HCV spontaneous clearance (p = 0.010; 0.503 (0.297 to 0.850).
This study shows an association between spontaneous persistent HIV-control and HCV spontaneous clearance. The study findings support the idea of preserved immune mechanisms in persistent HIV control implicated in HCV spontaneous clearance. These results highlight persistent HIV-controllers but not transient controllers as a good model of functional HIV cure. | es_ES |
dc.description.sponsorship | This work was supported by the Instituto de Salud Carlos III (research contracts CPII014/00025 to E.R.‐M., and FI14/00431 to L.T.‐D. and research projects PI12/02283, PI16/00684, PI19/01127 to E.R.‐M.) and Red Temática de Investigación Cooperativa en SIDA (Projects RD12/0017/0029, RD12/0017/0031, and RD16/0025/0020 and RD16/0025/0013), which is included in the Acción Estratégica en Salud, Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica 2008 to 2011 and 2013 to 2016, Instituto de Salud Carlos III, Fondos FEDER. E.R.‐M. was supported by Consejería de Salud y Bienestar Social of Junta de Andalucía through the Nicolás Monardes program (C‐0032/17), N Rallón is a Miguel Servet investigator from the Spanish Carlos III Institute of Health (ISCIII), grant CP14/00198, Madrid, Spain and B.D.M. received a grant from The Spanish Ministry of Education (FPU13/02451). Work in CL‐G’s laboratory was supported by grants SAF (2010 to 17226) and (2016‐77894‐R) from MINECO (Spain) and FIS (PI 13/02269, ISCIII) and in part by the RIS‐RETIC grants RD06/006/0036 and RD12/0017/0028 funded by the ISC III‐FEDER. MP has a contract of RIS‐RETIC RD12/0017/0036. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Wiley | es_ES |
dc.type.hasVersion | VoR | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject | HIV | es_ES |
dc.subject | HCV | es_ES |
dc.subject | HIV-controllers | es_ES |
dc.subject | Persistent | es_ES |
dc.subject | Transient | es_ES |
dc.subject | HCV spontaneous clearance | es_ES |
dc.title | Persistent HIV-controllers are more prone to spontaneously clear HCV: a retrospective cohort study | en |
dc.type | journal article | es_ES |
dc.rights.license | Atribución 4.0 Internacional | * |
dc.identifier.pubmedID | 32909370 | es_ES |
dc.format.volume | 23 | es_ES |
dc.format.number | 9 | es_ES |
dc.format.page | e25607 | es_ES |
dc.identifier.doi | 10.1002/jia2.25607 | es_ES |
dc.contributor.funder | Instituto de Salud Carlos III | |
dc.contributor.funder | Red Temática Cooperativa de Investigación en Sida (España) | |
dc.contributor.funder | Gobierno de Andalucía | |
dc.contributor.funder | Ministerio de Educación (España) | |
dc.contributor.funder | Ministerio de Economía y Competitividad (España) | |
dc.contributor.funder | Redes Tematicas de Investigacion Cooperativa en Salud (España) | |
dc.description.peerreviewed | Sí | es_ES |
dc.identifier.e-issn | 1758-2652 | es_ES |
dc.relation.publisherversion | https://doi.org/10.1002/jia2.25607 | es_ES |
dc.identifier.journal | Journal of the International AIDS Society | es_ES |
dc.repisalud.centro | ISCIII::Centro Nacional de Microbiología | es_ES |
dc.repisalud.institucion | ISCIII | es_ES |
dc.rights.accessRights | open access | es_ES |
dc.relation.projectFECYT | info:eu_repo/grantAgreement/ES/RD12/0017/0029 | |
dc.relation.projectFECYT | info:eu_repo/grantAgreement/ES/RD12/0017/0031 | |
dc.relation.projectFECYT | info:eu_repo/grantAgreement/ES/RD16/0025/0020 | |
dc.relation.projectFECYT | info:eu_repo/grantAgreement/ES/RD16/0025/0013 | |
dc.relation.projectFECYT | info:eu_repo/grantAgreement/ES/FPU13/02451 | |
dc.relation.projectFECYT | info:eu_repo/grantAgreement/ES/SAF2016‐77894‐R | |
dc.relation.projectFECYT | info:eu_repo/grantAgreement/ES/SAF2010‐17226 | |
dc.relation.projectFIS | info:eu_repo/grantAgreement/ES/CPII014/00025 | |
dc.relation.projectFIS | info:eu_repo/grantAgreement/ES/FI14/00431 | |
dc.relation.projectFIS | info:eu_repo/grantAgreement/ES/PI12/02283 | |
dc.relation.projectFIS | info:eu_repo/grantAgreement/ES/PI16/00684 | |
dc.relation.projectFIS | info:eu_repo/grantAgreement/ES/PI19/01127 | |
dc.relation.projectFIS | info:eu_repo/grantAgreement/ES/PI13/02269 | |
dc.relation.projectFIS | info:eu_repo/grantAgreement/ES/CP14/00198 | |
dc.relation.projectFIS | info:eu_repo/grantAgreement/ES/RD06/006/0036 | |
dc.relation.projectFIS | info:eu_repo/grantAgreement/ES/RD12/0017/0028 | |
dc.relation.projectFIS | info:eu_repo/grantAgreement/ES/RD12/0017/0036 | |